Knežević, S.; Filippi-Arriaga, F.; Belančić, A.; Božina, T.; Mršić-Pelčić, J.; Vitezić, D.
Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review. Diabetology 2024, 5, 406-429.
https://doi.org/10.3390/diabetology5040031
AMA Style
Knežević S, Filippi-Arriaga F, Belančić A, Božina T, Mršić-Pelčić J, Vitezić D.
Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review. Diabetology. 2024; 5(4):406-429.
https://doi.org/10.3390/diabetology5040031
Chicago/Turabian Style
Knežević, Sandra, Francesca Filippi-Arriaga, Andrej Belančić, Tamara Božina, Jasenka Mršić-Pelčić, and Dinko Vitezić.
2024. "Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review" Diabetology 5, no. 4: 406-429.
https://doi.org/10.3390/diabetology5040031
APA Style
Knežević, S., Filippi-Arriaga, F., Belančić, A., Božina, T., Mršić-Pelčić, J., & Vitezić, D.
(2024). Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review. Diabetology, 5(4), 406-429.
https://doi.org/10.3390/diabetology5040031
